Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

8 results
Display

A Case of Acute Antibody-Mediated Rejection Developed after Pretreatment with Rituximab and Plasma Exchange in a Highly-Sensitized Recipient with a Deceased Donor Kidney

Kim SM, Oh JS, Sin YH, Kim JK, Park JI, Huh K, Kim YJ

  • KMID: 2324219
  • J Korean Soc Transplant.
  • 2012 Jun;26(2):125-130.
Acute antibody-mediated rejection is the major cause of graft failure in the early stage of kidney transplantation. Preoperative treatment and early diagnosis of acute rejection is very important to prevent...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Use of Continuous Venovenous Hemodiafiltration to Enhance the Elimination of Serum Pentobarbital before Diagnosis of Brain Death

Lee JM, Lee YJ, Bang ES, Chu IS, Kim SH

  • KMID: 2324218
  • J Korean Soc Transplant.
  • 2012 Jun;26(2):120-124.
Continuous venovenous hemodiafiltration (CVVHDF) was used to eliminate pentobarbital from the blood of a 30-year-old potentially brain dead male patient with traumatic intracranial hemorrhage after a motorcycle accident. The Acute...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Severity of End-stage Liver Disease in Liver Transplant Candidate; Comparison of KONOS Status with MELD Score

Joo DJ, Kim MS, Kim SI, Jeon KO, Huh KH, Choi GH, Choi JS

  • KMID: 2324217
  • J Korean Soc Transplant.
  • 2012 Jun;26(2):112-119.
BACKGROUND: We have allocated liver according to the Korean Network Organ Sharing (KONOS) status. However, it was necessary to change the system to a more adequate and objective system. We...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Preliminary Results of Donor Action in Korea

Park SJ, Yoon YC, Cho WH, Roels L, Smits J, Cohen B, Kim NY, Bok CH, Kang SW, Kim TH, Lee HS, Kim YH

  • KMID: 2324216
  • J Korean Soc Transplant.
  • 2012 Jun;26(2):101-111.
BACKGROUND: Donor Action (DA) is a well-known program used to evaluate the potential of organ donors and to survey hospital attitudes toward organ donation in a region or nation. DA...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Evaluation of Flow Cytometric Crossmatch Results in Comparison with Donor-specific Antibodies Detected by Luminex-PRA Tests in Organ Transplantation Patients

Kim SY, Han BY, Hyun J, Joo SY, Song EY, Park MH

  • KMID: 2324215
  • J Korean Soc Transplant.
  • 2012 Jun;26(2):92-100.
BACKGROUND: Two of the most sensitive methods for detecting donor-specific HLA antibodies (DSAs) are solid phase panel reactive antibody (PRA) assay using Luminex platform (Luminex-PRA), and a cell-based flow cytometric...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Safety and Efficacy of the Early Introduction of Everolimus (Certican(R)) with Low Dose of Cyclosporine in de Novo Kidney Recipients after 1 Month of Transplantation (Preliminary Results)

Oh CK, Ha JW, Kim YH, Kim YL, Kim YS

  • KMID: 2324214
  • J Korean Soc Transplant.
  • 2012 Jun;26(2):83-91.
BACKGROUND: Everolimus and cyclosporine (CsA) exhibit synergistic immunosuppressive activity when used in combination. We analyzed preliminary data about the use of everolimus with a CsA-sparing strategy in de novo renal...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Application of Regulatory T Cells in Transplantation Field

Kim YH, Kim HJ, Kim JS, Park CG

  • KMID: 2324213
  • J Korean Soc Transplant.
  • 2012 Jun;26(2):74-82.
The development of immunosuppressant treatments has enabled remarkable progress in the tissue and organ transplantation field by helping to prevent acute graft rejection. However, complications related to transplantation, such as...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Strategies to Overcome Memory T Cells Mediatied Allograft Injury

Kim BS

  • KMID: 2324212
  • J Korean Soc Transplant.
  • 2012 Jun;26(2):69-73.
During the last few decades our knowledge of transplantation has been remarkably expanded to the point where transplants are a standard treatment modality. However, despite the fact that certain tolerogenic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2021 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr